N-Cyclopropyl-N'-piperidin-2-ylMethyl-pyriMidine-4,6-diaMine hydrochloride
- $429.07 - $496
- Product name: N-Cyclopropyl-N'-piperidin-2-ylMethyl-pyriMidine-4,6-diaMine hydrochloride
- CAS: 1353956-39-4
- MF: C13H22ClN5
- MW: 283.80028
- EINECS:
- MDL Number:MFCD21098726
- Synonyms:N4-Cyclopropyl-N6-(piperidin-2-ylMethyl)pyriMidine-4,6-diaMine hydrochloride;N-Cyclopropyl-N'-piperidin-2-ylMethyl-pyriMidine-4,6-diaMine hydrochloride;4-N-cyclopropyl-6-N-(piperidin-2-ylmethyl)pyrimidine-4,6-diamine
3 prices
Selected condition:
Brand
- Alichem
- Chemenu
- Crysdot
Package
- 1g
- ManufacturerAlichem
- Product number1353956394
- Product descriptionN4-Cyclopropyl-N6-(piperidin-2-ylmethyl)pyrimidine-4,6-diaminehydrochloride
- Packaging1g
- Price$429.07
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM165919
- Product descriptionN4-Cyclopropyl-N6-(piperidin-2-ylmethyl)pyrimidine-4,6-diaminehydrochloride 95%
- Packaging1g
- Price$464
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11286196
- Product descriptionN4-Cyclopropyl-N6-(piperidin-2-ylmethyl)pyrimidine-4,6-diaminehydrochloride 95+%
- Packaging1g
- Price$496
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 1353956394 | N4-Cyclopropyl-N6-(piperidin-2-ylmethyl)pyrimidine-4,6-diaminehydrochloride | 1g | $429.07 | 2021-12-16 | Buy |
Chemenu | CM165919 | N4-Cyclopropyl-N6-(piperidin-2-ylmethyl)pyrimidine-4,6-diaminehydrochloride 95% | 1g | $464 | 2021-12-16 | Buy |
Crysdot | CD11286196 | N4-Cyclopropyl-N6-(piperidin-2-ylmethyl)pyrimidine-4,6-diaminehydrochloride 95+% | 1g | $496 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|